Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia

NCT ID: NCT03869775

Last Updated: 2019-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

240 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2020-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia; Adverse Effect

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

no additional disease

perfusion index monitor

Intervention Type DEVICE

perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor

working group-1

additional disease only DM and no cardıovascular autonomous neuropathıa

perfusion index monitor

Intervention Type DEVICE

perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor

ewing test

Intervention Type DIAGNOSTIC_TEST

ewing tests will be applied to diabetic patients undergoing spinal anesthesia for cardıovascular autonomous neuropathıa diagnosis

working group-2

additional disease only DM and pozitif cardıovascular autonomous neuropathıa

perfusion index monitor

Intervention Type DEVICE

perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor

ewing test

Intervention Type DIAGNOSTIC_TEST

ewing tests will be applied to diabetic patients undergoing spinal anesthesia for cardıovascular autonomous neuropathıa diagnosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

perfusion index monitor

perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor

Intervention Type DEVICE

ewing test

ewing tests will be applied to diabetic patients undergoing spinal anesthesia for cardıovascular autonomous neuropathıa diagnosis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* the patient will be operated with spinal anesthesia
* over 18 years
* no additional disease and only DM

Exclusion Criteria

* patients with additional disease
* patients under 18 years of age
* patients contraindicated in spinal anesthesia
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erzincan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

faruk subasi

Asistant Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Erzincanu

Erzincan, Merkez, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

FARUK SUBAŞI

Role: CONTACT

5414247924

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

FARUK SUBAŞI

Role: primary

5414247924

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ErzincanU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.